TLR3 and neuroblastoma: In patients with hepatocellular carcinoma (HCC), neuroblastomas or esophageal squamous cell carcinoma, TLR3 was associated with greater survival7,10,27, while its expression was significantly associated with poor overall survival in patients with resectable gastric tumors or breast cancer8,9.